Abstract
Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.
Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin
Recent Patents on Anti-Infective Drug Discovery
Title: Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man
Volume: 4 Issue: 2
Author(s): Vincenzo Savini, Chiara Catavitello, Azaira Bianco, Andrea Balbinot and Domenico D'Antonio
Affiliation:
Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin
Abstract: Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.
Export Options
About this article
Cite this article as:
Savini Vincenzo, Catavitello Chiara, Bianco Azaira, Balbinot Andrea and D'Antonio Domenico, Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man, Recent Patents on Anti-Infective Drug Discovery 2009; 4 (2) . https://dx.doi.org/10.2174/157489109788490352
DOI https://dx.doi.org/10.2174/157489109788490352 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Neuroprotective Effects of Intravenous Anesthetics: A New Critical Perspective
Current Pharmaceutical Design The Science of Hypoglycemia in Patients with Diabetes
Current Diabetes Reviews Clinical Significance of the Cardio-Ankle Vascular Index (CAVI) in Hypertension
Current Hypertension Reviews Cardiac Imaging in Heart Failure with Comorbidities
Current Cardiology Reviews Cardiac Arrest in the Catheterization Laboratory
Current Cardiology Reviews Novel Oral Anticoagulants: Recommendations for Patient Evaluation, Treatment Initiation, Follow-up and Perioperative Management
Cardiovascular & Hematological Disorders-Drug Targets Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology Review of Cell and Organ Printing Patents
Recent Patents on Biomedical Engineering (Discontinued) Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart Therapies
Cardiovascular & Hematological Disorders-Drug Targets Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients
Current Vascular Pharmacology Right Atrial Thrombus in a Patient of Rheumatic Heart Disease with Severe Mitral Regurgitation: A Rare Association
Cardiovascular & Hematological Disorders-Drug Targets Impact of Magnetic Nanoparticles in Biomedical Applications
Recent Patents on Drug Delivery & Formulation Microfluidic Devices for Automation of Assays on Drosophila Melanogaster for Applications in Drug Discovery and Biological Studies
Current Pharmaceutical Biotechnology The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
Current Pharmaceutical Design Endothelin-1 and the Aortic Valve
Current Vascular Pharmacology Critical Illness in Obstetric Patients: Venous Thromboembolism in Pregnancy
Current Women`s Health Reviews Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design Strategies to Avoid TAVI-related Acute Kidney Injury
Current Pharmaceutical Design Intervertebral Disc and Nucleus Replacement Devices and Instrumentations
Recent Patents on Biomedical Engineering (Discontinued) Patent Selections
Recent Patents on Cardiovascular Drug Discovery